1. Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses. (2nd September 2017) Authors: Ghinnagow, Reem; De Meester, Julie; Cruz, Luis Javier; Aspord, Caroline; Corgnac, Stéphanie; Macho-Fernandez, Elodie; Soulard, Daphnée; Fontaine, Josette; Chaperot, Laurence; Charles, Julie; Soncin, Fabrice; Mami-Chouaib, Fathia; Plumas, Joel; Faveeuw, Christelle; Trottein, François Journal: Oncoimmunology Issue: Volume 6:Number 9(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗